Clik here to view.
Brands Make A Comeback; OTC Market Resilient During Recession
The U.S. OTC market is often a challenging market to make predictions about. There are so many instances where companies, brands, consumers, and even regulators buck trends that there are often reasons...
View ArticleClik here to view.
WEBINAR – Nonprescription Drugs USA 2009 Key Highlights
Kline’s Healthcare Industry Manager Laura Mahecha will discuss current trends in the U.S. nonprescription drugs market in a web conference, followed by a live question and answer session. REGISTER...
View ArticleClik here to view.
Rx-to-OTC Switches Energize Solid OTC Drug Market Growth
Rx-to-OTC switch brands continue to be major game changers within the OTC market, whether promoting strong gains or causing steep declines. Aided by the launch of Rx-to-OTC switch brand Allegra...
View ArticleClik here to view.
FDA Initiative Forms Basis for Healthy Rx-to-OTC Switch Opportunities
In the not so distant past, the U.S. FDA has taken a rather conservative stance concerning Rx-to-OTC switches. Many potential categories have been discounted as not safe and/or effective without a...
View ArticleClik here to view.
Sales Resurgence of U.S. OTCs in 2013 Helps the Market Overcome Flat Sales...
According to Kline’s Nonprescription Drugs USA study, the U.S. OTC market grew over 3.0% during 2013 to reach $23.5 billion at the manufacturers’ level. Driven by strong sales gains in analgesics,...
View ArticleClik here to view.
U.S. OTC Marketers Vault Ahead of the Competition
Top Players in the U.S. OTC Market While the U.S. OTC market is not highly dynamic in terms of growth, its competitive landscape has changed significantly over the past five years, with the top 10...
View ArticleClik here to view.
New Acne Elimination Switches and Devices Heat Up the OTC Market
Acne Remedies The U.S. OTC market has enjoyed solid momentum in recent years, increasing far beyond the typical 2% to 3% annual growth it used to experience. Strong advertising and promotional...
View ArticleClik here to view.
OTC contraceptives and personal lubricants propel sales gains for OTC...
The emergency contraceptives segments of the OTC feminine products market, particularly Teva Pharmaceuticals’ Plan B and store brand copies of Plan B, drove significant gains for the otherwise flat...
View Article
